These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28702876)

  • 21. Biochemical basis of the beta-glucuronidase gene defect causing canine mucopolysaccharidosis VII.
    Ray J; Scarpino V; Laing C; Haskins ME
    J Hered; 1999; 90(1):119-23. PubMed ID: 9987917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal osteoclast morphology and bone remodeling in a murine model of a lysosomal storage disease.
    Monroy MA; Ross FP; Teitelbaum SL; Sands MS
    Bone; 2002 Feb; 30(2):352-9. PubMed ID: 11856642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme replacement in murine mucopolysaccharidosis type VII: neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy.
    Vogler C; Levy B; Galvin NJ; Thorpe C; Sands MS; Barker JE; Baty J; Birkenmeier EH; Sly WS
    Pediatr Res; 1999 Jun; 45(6):838-44. PubMed ID: 10367775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery.
    Richard M; Arfi A; Seguin J; Gandolphe C; Scherman D
    Gene Ther; 2009 Jun; 16(6):746-56. PubMed ID: 19357715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed hypertrophic differentiation of epiphyseal chondrocytes contributes to failed secondary ossification in mucopolysaccharidosis VII dogs.
    Peck SH; O'Donnell PJ; Kang JL; Malhotra NR; Dodge GR; Pacifici M; Shore EM; Haskins ME; Smith LJ
    Mol Genet Metab; 2015 Nov; 116(3):195-203. PubMed ID: 26422116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late diagnosis of mucopolysaccharidosis type IVB and successful aortic valve replacement in a 60-year-old female patient.
    Dostalova G; Hlubocka Z; Lindner J; Hulkova H; Poupetova H; Vlaskova H; Sikora J; Linhart A; Zeman J; Magner M
    Cardiovasc Pathol; 2018; 35():52-56. PubMed ID: 29800929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycosaminoglycan storage in cultured neonatal murine mucopolysaccharidosis type VII neuroglial cells and correction by beta-glucuronidase gene transfer.
    Taylor RM; Wolfe JH
    J Neurochem; 1997 May; 68(5):2079-85. PubMed ID: 9109535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapy for murine mucopolysaccharidosis type VII.
    Sands MS; Wolfe JH; Birkenmeier EH; Barker JE; Vogler C; Sly WS; Okuyama T; Freeman B; Nicholes A; Muzyczka N; Chang PL; Axelrod HR
    Neuromuscul Disord; 1997 Jul; 7(5):352-60. PubMed ID: 9267850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of ventricular and intravenous lentiviral-mediated gene therapy for murine MPS VII.
    Bielicki J; McIntyre C; Anson DS
    Mol Genet Metab; 2010 Dec; 101(4):370-82. PubMed ID: 20864369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy.
    Xu L; Mango RL; Sands MS; Haskins ME; Ellinwood NM; Ponder KP
    Mol Ther; 2002 Dec; 6(6):745-58. PubMed ID: 12498771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical course of sly syndrome (mucopolysaccharidosis type VII).
    Montaño AM; Lock-Hock N; Steiner RD; Graham BH; Szlago M; Greenstein R; Pineda M; Gonzalez-Meneses A; Çoker M; Bartholomew D; Sands MS; Wang R; Giugliani R; Macaya A; Pastores G; Ketko AK; Ezgü F; Tanaka A; Arash L; Beck M; Falk RE; Bhattacharya K; Franco J; White KK; Mitchell GA; Cimbalistiene L; Holtz M; Sly WS
    J Med Genet; 2016 Jun; 53(6):403-18. PubMed ID: 26908836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Widespread correction of lysosomal storage following intrahepatic injection of a recombinant adeno-associated virus in the adult MPS VII mouse.
    Sferra TJ; Backstrom K; Wang C; Rennard R; Miller M; Hu Y
    Mol Ther; 2004 Sep; 10(3):478-91. PubMed ID: 15336648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active site mutant transgene confers tolerance to human beta-glucuronidase without affecting the phenotype of MPS VII mice.
    Sly WS; Vogler C; Grubb JH; Zhou M; Jiang J; Zhou XY; Tomatsu S; Bi Y; Snella EM
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2205-10. PubMed ID: 11226217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accumulation of abnormal amounts of glycosaminoglycans in murine mucopolysaccharidosis type VII neural progenitor cells does not alter the growth rate or efficiency of differentiation into neurons.
    Heuer GG; Skorupa AF; Prasad Alur RK; Jiang K; Wolfe JH
    Mol Cell Neurosci; 2001 Jan; 17(1):167-78. PubMed ID: 11161477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residual glycosaminoglycan accumulation in mitral and aortic valves of a patient with attenuated MPS I (Scheie syndrome) after 6 years of enzyme replacement therapy: Implications for early diagnosis and therapy.
    Sato Y; Fujiwara M; Kobayashi H; Yoshitake M; Hashimoto K; Oto Y; Ida H
    Mol Genet Metab Rep; 2015 Dec; 5():94-97. PubMed ID: 28649551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and Emerging Treatment Strategies for Mucopolysaccharidosis VII (Sly Syndrome).
    Poswar FO; Henriques Nehm J; Kubaski F; Poletto E; Giugliani R
    Ther Clin Risk Manag; 2022; 18():1143-1155. PubMed ID: 36578769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function.
    O'Connor LH; Erway LC; Vogler CA; Sly WS; Nicholes A; Grubb J; Holmberg SW; Levy B; Sands MS
    J Clin Invest; 1998 Apr; 101(7):1394-400. PubMed ID: 9525982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinal function is improved in a murine model of a lysosomal storage disease following bone marrow transplantation.
    Ohlemiller KK; Vogler CA; Roberts M; Galvin N; Sands MS
    Exp Eye Res; 2000 Nov; 71(5):469-81. PubMed ID: 11040082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials.
    Qi Y; McKeever K; Taylor J; Haller C; Song W; Jones SA; Shi J
    Clin Pharmacokinet; 2019 May; 58(5):673-683. PubMed ID: 30467742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of MPS VII mouse (Gus(tm(hE540A x mE536A)Sly)) doubly tolerant to human and mouse beta-glucuronidase.
    Tomatsu S; Orii KO; Vogler C; Grubb JH; Snella EM; Gutierrez M; Dieter T; Holden CC; Sukegawa K; Orii T; Kondo N; Sly WS
    Hum Mol Genet; 2003 May; 12(9):961-73. PubMed ID: 12700165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.